Once rapidly fatal, neglected, and orphan diseases without approved therapeutic options, systemic amyloidoses are now highly ...
State-level AI laws are being enacted at a rapid pace, but this is creating a Byzantine array of AI restrictions. AI makers struggle. An AI Insider analysis and scoop.